| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Family Service League is a nationally accredited human services agency that has taken an active role in strengthening families and empowering the residents of Long Island for more than 90 years. We currently have over 50 programs in 21 locations, including 5 Family Centers, designed to help children, families in crisis, senior citizens, people who are homeless, unemployed, or mentally ill. Family Service League works to give them the resources they need in order to be self-reliant and productive members of our communities.
BioMS Medical Corporation is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com